|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: SIGA PHARMACEUTICALS INC, 10-Q, 2000-08-14 |
Next: SIGA PHARMACEUTICALS INC, S-3, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 4,120,580
<SECURITIES> 0
<RECEIVABLES> 24,813
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 4,190,372
<PP&E> 1,943,377
<DEPRECIATION> 736,897
<TOTAL-ASSETS> 5,548,100
<CURRENT-LIABILITIES> 839,290
<BONDS> 0
0
0
<COMMON> 728
<OTHER-SE> 22,018,799
<TOTAL-LIABILITY-AND-EQUITY> 5,548,100
<SALES> 0
<TOTAL-REVENUES> 171,173
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 2,996,094
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (3,084,651)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,084,651)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,084,651)
<EPS-BASIC> (0.44)
<EPS-DILUTED> (0.44)
</TABLE>
|
|